GEA Group reaffirms 2026 outlook with order intake expected to top €6 billion

GEA Group has reaffirmed its 2026 financial guidance, projecting annual order intake to exceed €6 billion. The company cited strong momentum in its project pipeline and healthy base-order activity across several sectors, including food, beverage, dairy, and pharmaceutical markets.

Ahead of its third-quarter results, GEA expects organic sales growth of 6% to 8% for the full year. The company also anticipates an EBITDA margin before restructuring expenses of 17% to 17.4% and a return on capital employed between 36% and 40%. In the first half of 2026, GEA reported organic order intake growth of 10.7%.

In related market activity, Barclays raised its price target for GEA stock from €78.00 to €79.00, maintaining an ‘Overweight’ rating. Analysts pointed to stable demand and expected organic order growth as key drivers for the company, which specializes in systems and components for the food and pharma industries.